The corticosteroids market, while mature, continues to experience steady growth, driven by the widespread use of these drugs in treating a variety of inflammatory and autoimmune conditions. Valued at USD 5.70 billion in 2023, the market is projected to reach USD 8.53 billion by 2032, exhibiting a CAGR of 4.6% during the forecast period.
Market Overview:
Corticosteroids are a class of steroid hormones that reduce inflammation and suppress the immune system. They are available in various forms, including oral tablets, topical creams, injections, and inhalers, and are used to treat a broad range of conditions, from asthma and allergies to arthritis and autoimmune diseases.
Some of the major players operating in the global market include:
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca plc
- Bausch Health Companies Inc.
- Bayer AG
- Cipla Limited
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Johnson & Johnson
- Lupin Limited
- Merck & Co., Inc.
- Novartis International AG
- Pfizer Inc.
- Sanofi S.A.
Key Drivers of Market Growth:
- High Prevalence of Inflammatory and Autoimmune Diseases: The increasing prevalence of chronic inflammatory and autoimmune diseases, such as rheumatoid arthritis, asthma, and inflammatory bowel disease, is a major driver of the corticosteroids market.
- Versatility of Corticosteroids: Corticosteroids are effective in treating a wide range of conditions, making them a versatile and widely used class of drugs.
- Advancements in Formulation and Delivery: Ongoing research and development are leading to improved formulations and delivery methods for corticosteroids, such as inhaled corticosteroids for asthma and topical corticosteroids for skin conditions, which can enhance efficacy and reduce side effects.
Recent Developments:
- Santhera Pharmaceuticals’ Agamree Approval: The FDA approval of Agamree (vamorolone) for Duchenne muscular dystrophy represents a significant advancement in the treatment of this rare genetic disorder. It also highlights the ongoing development of novel corticosteroid therapies.
- Salvat’s Ocular Corticosteroid Development: The development of an ocular corticosteroid nanoemulsion for post-ocular surgery inflammation and pain demonstrates the continued innovation in corticosteroid formulations and delivery methods. This specific development targets a significant unmet need in ophthalmology.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
Corticosteroids Market, Route of Administration Outlook (Revenue – USD Billion, 2019-2032)
- Inhaled
- Topical
- Injectable
- Oral
Corticosteroids Market, Type Outlook (Revenue – USD Billion, 2019-2032)
- Mineralocorticoids
- Glucocorticoids
Corticosteroids Market, Application Outlook (Revenue – USD Billion, 2019-2032)
- Skin Allergies
- Gastroenterology
- Endocrinology
- Acute Respiratory Diseases
- Rheumatology Indications
- Others
The research study includes segmental analysis that divides the market into distinct groups or segments based on common characteristics. With market segmentation, businesses can identify specific customer groups that are more likely to be interested in specific products or services. Also, it enables these businesses to focus their marketing efforts and resources more efficiently, leading to higher conversion rates and improved return on investment. Furthermore, segmentation analysis helps companies develop personalized products or services, which can result in increased customer loyalty and improved customer satisfaction.
Market Trends:
- Localized Drug Delivery: There is a growing trend towards localized drug delivery for corticosteroids, such as inhaled corticosteroids for asthma and topical corticosteroids for skin conditions, to minimize systemic side effects.
- Combination Therapies: Corticosteroids are often used in combination with other therapies, such as bronchodilators for asthma or immunosuppressants for autoimmune diseases, to improve patient outcomes.
- Focus on Safety: Research and development efforts are focused on developing safer corticosteroid therapies with fewer side effects and a lower risk of long-term complications.
Market Opportunities:
- Emerging Markets: The increasing access to healthcare in emerging markets presents growth opportunities for the corticosteroids market.
- Rare Diseases: The development of corticosteroid therapies for rare diseases, such as Duchenne muscular dystrophy, represents a growing area of focus for pharmaceutical companies.
- Personalized Medicine: The use of biomarkers and genetic testing to personalize corticosteroid therapy, tailoring treatment to individual patients, is an emerging trend in the market.
Challenges:
- Side Effects: Corticosteroids can cause a range of side effects, particularly with long-term use, including weight gain, bone loss, and immune suppression.
- Risk of Infection: Corticosteroids can suppress the immune system, increasing the risk of infection.
- Dependence: Long-term use of corticosteroids can lead to dependence and withdrawal symptoms if the medication is stopped abruptly.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/corticosteroids-market
Table of Contents:
- Global Corticosteroids Market Insights
4.1. Corticosteroids Market – Application Snapshot
4.2. Corticosteroids Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Advancements in drug formulations are projected to spur the product demand
4.2.1.2. Rising aging population is expected to drive market growth
4.2.2. Restraints and Challenges
4.2.2.1. Adverse reactions and side effects are likely to impede the market growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Corticosteroids Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Corticosteroids Market, by Route of Administration
5.1. Key Findings
5.2. Introduction
5.2.1. Global Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
5.3. Inhaled
5.3.1. Global Corticosteroids Market, by Inhaled, by Region, 2019-2032 (USD Billion)
5.4. Topical
5.4.1. Global Corticosteroids Market, by Topical, by Region, 2019-2032 (USD Billion)
5.5. Injectable
5.5.1. Global Corticosteroids Market, by Injectable, by Region, 2019-2032 (USD Billion)
5.6. Oral
5.6.1. Global Corticosteroids Market, by Oral, by Region, 2019-2032 (USD Billion)
6. Global Corticosteroids Market, by Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Corticosteroids Market, by Type, 2019-2032 (USD Billion)
6.3. Mineralocorticoids
6.3.1. Global Corticosteroids Market, by Mineralocorticoids, by Region, 2019-2032 (USD Billion)
6.4. Glucocorticoids
6.4.1. Global Corticosteroids Market, by Glucocorticoids, by Region, 2019-2032 (USD Billion)
Conclusion:
The corticosteroids market is a mature market with steady growth prospects, driven by the high prevalence of inflammatory and autoimmune diseases. While challenges such as side effects and the risk of infection persist, ongoing research and development are leading to safer and more effective therapies. The market will likely continue to evolve with the development of new formulations, delivery methods, and combination therapies, as well as a greater emphasis on personalized medicine approaches.
More Trending Latest Reports By Polaris Market Research: